White Gold Gets Infusion of Capital, Knowledge
Source: Streetwise Reports��(12/6/21)
White Gold Corp. will use an investment of CA$9 million through strategic partner and investor Agnico Eagle Mines Ltd. for working capital and general corporate purposes. But the transaction has another benefit: It gives White Gold access to a tremendous level of expertise across all areas of mining. More >

Medical Device Firm Engages Distributor for Its TransDermal Infusion System
Source: Streetwise Reports��(12/6/21)
Sensus Healthcare's "needle-free treatment presents a clear competitive advantage in the aesthetic dermatology space," an H.C. Wainwright & Co. report noted. More >

Phase Two Studies Start for Therapy for Chemo-Treated Breast Cancer Patients
Source: Streetwise Reports��(12/6/21)
New clinical trials for G1 Therapeutics’ Cosela are “central to our investment thesis,” H.C. Wainright & Co. noted in a new research report. More >

Biopharma Launches Clinical Trial of Primary Asset in Endometrial Cancer
Source: Streetwise Reports��(12/6/21)
"Solid tumors offers a substantial opportunity for Karyopharm Therapeutics' Xpovio (selinexor) that perhaps investors have not yet realized," noted an H.C. Wainwright & Co. report. More >

Biotech Firm’s T-Cell Therapy Gets Positive Results in B-Cell Non-Hodgkin’s Lymphoma Study
Source: Streetwise Reports��(12/6/21)
Adicet Bio Inc. shares traded 37% higher after the company reported positive interim data from its Phase 1 GLEAN Study of ADI-001, which the firm noted is the first-ever allogeneic, off-the-shelf, gamma delta CAR T investigational cell therapy. More >

Top Miners’ Share Prices Compelling as Growth Continues
Source: Adrian Day for Streetwise Reports��(12/6/21)
Adrian Day, in the Global Analyst newsletter, reviews developments at several companies, three of his favorite large miners and one favorite junior, all of which he says are at very compelling levels to buy. More >

Inflationary Hubris, the Fed & Gold: Can Inflation Actually Be Good for Everyday Americans?
Source: Michael Ballanger for Streetwise Reports��(12/6/21)
Precious metals expert Michael Ballanger discusses Fed actions and how they affect precious metals. More >

Marvell Shares Rise Nearly 18% on Q3 Earnings & Q4 Revenue Outlook
Source: Streetwise Reports��(12/4/21)
Shares of Marvell Technology established a new 52-week high after the infrastructure semiconductor solutions firm reported Q3/22 financial results than included a 61% increase in YoY revenue. More >

The Best Game for Telcos to Get Into
Source: Streetwise Reports��(12/2/21)
Gaming is an estimated $192 billion market, and it is forecasted to grow to almost $400 billion by 2026. Sophic Capital makes the case that telcos need to evolve from being utilities to offering gaming services to attract and keep Gen-Z subscribers. More >

Firm With New eBook Platform Completes Reverse Takeover, Private Placement Underway
Source: Streetwise Reports��(12/2/21)
Legible Inc. began trading on the Canadian Stock Exchange under the ticker symbol READ after a three-way amalgamation closed. More >

Golden Sky Stock Rises on Strength of Yukon Drill Results
Source: Streetwise Reports��(12/1/21)
Golden Sky Minerals Corp.'s stock rose almost 20% on volume exceeding 43,000 shares in intraday trading on the strength of drill reports on a Yukon property. More >

Coverage Initiated on Firm 'Set to Become a Leading, US-Based ISR Uranium Developer'
��(12/1/21)
EnCore Energy's acquisition of Azarga Uranium is expected to close shortly, according to a Red Cloud Securities report. More >

Gold Terra Enters Into Option Agreement With Newmont to Purchase Con Mine
Source: The Critical Investor for Streetwise Reports��(12/1/21)
The Critical Investor discusses the benefits of the recently acquired Con Mine with Gold Terra Executive Chairman Gerald Panneton. More >

AI Vision Semiconductor Firm Posts 64% Increase in YoY Revenue Sending Shares Higher
Source: Streetwise Reports��(12/1/21)
Ambarella Inc. shares traded nearly 20% higher after the company reported Q3/22 financial results that included a 64% increase in YoY revenue together with higher gross margins. More >

Antibody-Drug Conjugate Developer Achieves High Objective Response Rates in Ovarian Cancer Study
Source: Streetwise Reports��(11/30/21)
ImmunoGen Inc. shares traded 30% higher after the company announced positive topline data from its pivotal Phase 3 SORAYA Trial of mirvetuximab soravtansine in platinum-resistant ovarian cancer. More >

Why Is PennyQueen Investing in This Uranium Company and Recommending It to Her Social Media Following?
Source: Penny Queen��(11/30/21)
PennyQueen, an investor and stock market social media community builder who focuses mostly on clean tech, explains why she has invested in this uranium company and recommended it to her social media following. More >

Aurania Resources in a Fire Sale
Source: Bob Moriarty for Streetwise Reports��(11/30/21)
Bob Moriarty of 321 Gold profiles Aurania Resources and explains why he believes its stock is attractively priced right now. More >

Biopharma Launches COVID Vaccine Program in South Africa & Mexico
Source: Streetwise Reports��(11/30/21)
Oramed Pharmaceuticals' oral vaccine offers "convenience and safety advantages as well as coverage of emergent variant strains," noted a Nov. 29, 2021 H.C. Wainwright & Co. report. More >

Emerging SARS-COv-2 Variant Is Revenue Growth Opportunity for Vaccine Developer
Source: Streetwise Reports��(11/30/21)
Just a few days after the WHO deemed the COVID-19 Omicron variant a serious global health concern, leading mRNA-based vaccine developers BioNTech and Pfizer, along with rival Moderna, advised that if needed, the companies would be capable of developing a vaccine for the new mutating strains within roughly 100 days. H.C. Wainwright & Co. commented in a research note that it reiterates its "Buy" rating for BioNTech SE. More >

Argentina Lithium Raises CA$4.99M in First Two Tranches of Non-Brokered Private Placement
Source: The Critical Investor��(11/30/21)
Argentina Lithium seems to be making the most of the ongoing lithium frenzy by battery producers, raising sufficient capital to fund exploration for their Argentinian lithium projects, scheduled for next quarter. More >

VOX Royalty - A Smart Way to Hedge Inflation Risk
Source: Maurice Jackson for Streetwise Reports��(11/30/21)
Vox Royalty is completing a banner year on its royalty portfolio, executing its royalty acquisition strategy, as the company now is on the cusp of having five producing royalty assets. More >

Metallic Minerals Advances Ultra High-Grade Keno Silver Project in Canada
Source: Maurice Jackson for Streetwise Reports��(11/30/21)
Metallic Minerals has just completed its most expansive drill program on the flagship ultra high-grade Keno Silver Project, located in the prolific Keno Silver District. In addition, the company has updates on the La Plata gold-silver-copper project, and the Klondike Alluvial Gold Projects. More >

NRx Pharma's COVID-19 Vaccine Displays Effectiveness Against Delta Variant in Phase 2 Clinical Trial
Source: Streetwise Reports��(11/29/21)
Shares of NRx Pharmaceuticals Inc. traded 50% higher after the company commented on new data released by the Israel Institute for Biological Research regarding the effectiveness of its BriLife® COVID-19 Vaccine against the SARS-CoV-2 "Delta" variant. More >

Mining Company 'Vectoring Toward Higher Grades' at Nevada Au-V Project
Source: Streetwise Reports��(11/29/21)
Phenom Resources' new drill results at its Carlin asset showed features of a Carlin-type system, but the grades were low, a Red Cloud Securities report noted. More >

Gene Therapy Firm's Shares Rise 120% on Topline Data From Pivotal Dystrophic EB Study
Source: Streetwise Reports��(11/29/21)
Shares of Krystal Biotech Inc. reached a new 52-week high after the company reported it met both primary and secondary endpoints in its pivotal GEM-3 trial of VYJUVEK™ in patients diagnosed with Dystrophic Epidermolysis Bullosa, a rare and severe skin disease. More >